Anders Kristoffer Lilja

Title: Innovations of Anders Kristoffer Lilja

Introduction

Anders Kristoffer Lilja is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of neuroscience through his innovative research and patenting activities. His work primarily focuses on the modulation of dopamine neurotransmission, which is crucial for various neurological functions.

Latest Patents

Anders Kristoffer Lilja holds a patent for "Modulators of dopamine neurotransmission." This patent includes new 3-substituted 4-(phenyl-N-alkyl)-piperazine and 4-(phenyl-N-alkyl)-piperidine compounds. The compounds are defined by a specific formula that outlines their chemical structure and potential applications. These compounds are designed to be used in pharmaceutical compositions for the treatment of disorders in the central nervous system.

Career Highlights

Anders is associated with A. Carlsson Research AB, where he continues to explore innovative solutions in the field of neuroscience. His work has led to advancements in understanding and treating neurological disorders, showcasing his commitment to improving health outcomes.

Collaborations

Anders collaborates with esteemed colleagues such as Clas Sonesson and Ingela Marianne Svan. Their combined expertise contributes to the success of their research initiatives and the development of new therapeutic approaches.

Conclusion

Anders Kristoffer Lilja's contributions to the field of neuroscience through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in the treatment of central nervous system disorders.